TY - JOUR
T1 - Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole
T2 - Case report and review of the literature
AU - Lycette, Jennifer L.
AU - Luoh, Shiuh Wen
AU - Beer, Tomasz M.
AU - Deloughery, Thomas G.
PY - 2006/10
Y1 - 2006/10
N2 - Hormonal therapy is the mainstay of adjuvant treatment for women with early-stage estrogen receptor-positive breast cancer. Recently, the aromatase inhibitors have moved to the forefront of adjuvant hormonal therapy, however, the adverse effects of these agents are not yet fully understood. It is generally accepted that tamoxifen, but not the aromatase inhibitors, is associated with an increased risk of thrombosis in women with breast cancer. Studies comparing aromatase inhibitors to tamoxifen in the adjuvant setting have reported a lower rate of venous thromboembolism with the aromatase inhibitors, yet the incidence of venous thromboembolism with these new agents is higher than that expected in the general population. Here we report a case of acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole, and review the literature on the incidence of venous thromboembolism during the use of aromatase inhibitors in the adjuvant setting.
AB - Hormonal therapy is the mainstay of adjuvant treatment for women with early-stage estrogen receptor-positive breast cancer. Recently, the aromatase inhibitors have moved to the forefront of adjuvant hormonal therapy, however, the adverse effects of these agents are not yet fully understood. It is generally accepted that tamoxifen, but not the aromatase inhibitors, is associated with an increased risk of thrombosis in women with breast cancer. Studies comparing aromatase inhibitors to tamoxifen in the adjuvant setting have reported a lower rate of venous thromboembolism with the aromatase inhibitors, yet the incidence of venous thromboembolism with these new agents is higher than that expected in the general population. Here we report a case of acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole, and review the literature on the incidence of venous thromboembolism during the use of aromatase inhibitors in the adjuvant setting.
KW - Anastrozole
KW - Aromatase inhibitors
KW - Breast cancer
KW - Pulmonary embolus
KW - Venous thromboembolism
UR - http://www.scopus.com/inward/record.url?scp=33748351155&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748351155&partnerID=8YFLogxK
U2 - 10.1007/s10549-006-9212-1
DO - 10.1007/s10549-006-9212-1
M3 - Review article
C2 - 16752073
AN - SCOPUS:33748351155
SN - 0167-6806
VL - 99
SP - 249
EP - 255
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 3
ER -